Cancer clinical trial participation: reimbursement of patient-incurred expenses not considered undue inducement - SB489

Coronavirus originating in Wuhan Province of China: Wisconsin Senate stands in solidarity with the Chinese people and condemns actions of the Communist Party of China for intentionally misleading the world and other actions - SR7

COVID-19 diagnosis or suspected diagnosis: prohibited actions by insurers, pharmacy benefit managers, and self-insured health plans [Sec. 13, 14, 20, 75, 78, 91, 93-95] - AB1038

COVID-19 diagnosis or suspected diagnosis: prohibited actions by insurers, pharmacy benefit managers, and self-insured health plans [Sec. 13, 14, 20, 75, 78, 91, 93-95] - SB932

COVID-19 pandemic: state government response - SB932

COVID-19 pandemic: state government response [A.Amdt.4: further revisions] - AB1038

COVID-19 related pharmaceutical and medical supplies: exemption from Unfair Sales Act - SB927

COVID-19 related pharmaceutical and medical supplies: exemption from Unfair Sales Act - AB1035

COVID-19 testing: health insurance policies required to cover without copayment or coinsurance [Sec. 92, 96] - AB1038

COVID-19 testing: health insurance policies required to cover without copayment or coinsurance [Sec. 92, 96] - SB932

Dementia training for health care providers: DHS to establish [Sec. 9119 (3); original bill only] - AB56

Dementia training for health care providers: DHS to establish [Sec. 9119 (3)] - SB59

Diabetes care and prevention action program: DHS to develop; DETF, DPI, and DOC provisions; biennial report required - AB238

Diabetes care and prevention action program: DHS to develop; DETF, DPI, and DOC provisions; biennial report required - SB217

Dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis to patient with end-stage renal disease: exemption from pharmacist license requirement, conditions set [S.Amdt.1: remove comma from ``dialysate, drugs"] - SB38

Dispensing, distributing, or selling dialysate, drugs, or devices necessary for providing home peritoneal kidney dialysis to patient with end-stage renal disease: exemption from pharmacist license requirement, conditions set - AB42

Emergency medical supply manufacturers, distributors, and sellers who donate or sell during the declared COVID-19 emergency: civil liability exemption established; conditions and charitable organization provision [Sec. 99-104] - SB932

Emergency medical supply manufacturers, distributors, and sellers who donate or sell during the declared COVID-19 emergency: civil liability exemption established; conditions and charitable organization provision [Sec. 99-104] - AB1038

Epidemiologist position in DHS dedicated to vector-borne diseases and a focus on Lyme disease - SB299

Epidemiologist position in DHS dedicated to vector-borne diseases and a focus on Lyme disease - AB314

Injury to first responder during 2020 public health emergency is presumed to be caused by the individual’s employment for WC purposes [Sec. 33, 34] [A.Amdt.4: exposure to COVID-19 specified] - AB1038

Insulin: cost sharing under health insurance policies and plans capped; OCI report required - AB411

Insulin: cost sharing under health insurance policies and plans capped; OCI report required - SB340

Kidney Month: March 2019 proclaimed as - AJR19

Lyme Disease Awareness Month: May 2019 recognized as - AJR35

Lyme Disease Awareness Month: May 2019 recognized as - SJR28

Lyme disease: DNR awareness campaign requirements, state park brochure provision - SB298

Lyme disease: DNR awareness campaign requirements, state park brochure provision - AB317

Lyme disease informational signs: DNR and DHS to collaborate on signs for state parks, trails, recreational areas, and forests - AB315